Management of Suspected Life-Threatening Perioperative Anaphylaxis and Risk Factors for Near-Fatal and Fatal Outcomes: A Retrospective Study in China.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Huamei Cai, Xiaowen Liu, Dingyi Wang, Weixia Li, Hongli Ma, Jing Zhao
{"title":"Management of Suspected Life-Threatening Perioperative Anaphylaxis and Risk Factors for Near-Fatal and Fatal Outcomes: A Retrospective Study in China.","authors":"Huamei Cai,&nbsp;Xiaowen Liu,&nbsp;Dingyi Wang,&nbsp;Weixia Li,&nbsp;Hongli Ma,&nbsp;Jing Zhao","doi":"10.2147/TCRM.S406515","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Perioperative anaphylaxis (POA) is an acute severe systemic hypersensitivity reaction characterized by life-threatening respiratory and circulatory collapse. In our previous study, we reported the epidemiology of suspected POA in China. In the present study, we aimed to elucidate the management and outcomes of these cases and further verify the risk factors for near-fatal and fatal outcomes.</p><p><strong>Patients and methods: </strong>This was a retrospective study of 447 cases of suspected life-threatening POA encountered at 112 tertiary hospitals in mainland China between September 2018 and August 2019. Patient characteristics, symptoms, duration of hypotension, treatments, and clinical outcomes were documented. Bivariate logistic regression was used to identify risk factors for near-fatal and fatal outcomes.</p><p><strong>Results: </strong>Most cases of suspected POA (89.9%) were recognized and treated within 5 min. Epinephrine was administered as the initial treatment in 232 (51.9%) cases. Corticosteroids (26.6%), other vasoactive drugs (18.3%), and bronchodilators (1.6%) were also administered as the initial treatment instead of epinephrine. The initial dosage of epinephrine (median, 35 µg) was insufficient according to the anaphylaxis guidelines. On multivariable analysis, age ≥65 years (odds ratio [OR] 7.48; 95% confidence interval [CI]: 1.33-41.87, <i>P</i>=0.022), ASA physical status IV (OR 17.68; 95% CI: 4.53-68.94; <i>P</i><0.001), and hypotension duration ≥15 min (OR 3.63; 95% CI: 1.11-11.87; <i>P</i>=0.033) were risk factors for fatal and near-fatal outcomes.</p><p><strong>Conclusion: </strong>Most cases in this study were managed in a timely manner, but the epinephrine application should be optimized according to the guidelines. Age ≥65 years, ASA physical status IV, and long-term hypotension were risk factors for near-fatal and fatal outcomes.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/60/be/tcrm-19-383.PMC10183184.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/TCRM.S406515","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Perioperative anaphylaxis (POA) is an acute severe systemic hypersensitivity reaction characterized by life-threatening respiratory and circulatory collapse. In our previous study, we reported the epidemiology of suspected POA in China. In the present study, we aimed to elucidate the management and outcomes of these cases and further verify the risk factors for near-fatal and fatal outcomes.

Patients and methods: This was a retrospective study of 447 cases of suspected life-threatening POA encountered at 112 tertiary hospitals in mainland China between September 2018 and August 2019. Patient characteristics, symptoms, duration of hypotension, treatments, and clinical outcomes were documented. Bivariate logistic regression was used to identify risk factors for near-fatal and fatal outcomes.

Results: Most cases of suspected POA (89.9%) were recognized and treated within 5 min. Epinephrine was administered as the initial treatment in 232 (51.9%) cases. Corticosteroids (26.6%), other vasoactive drugs (18.3%), and bronchodilators (1.6%) were also administered as the initial treatment instead of epinephrine. The initial dosage of epinephrine (median, 35 µg) was insufficient according to the anaphylaxis guidelines. On multivariable analysis, age ≥65 years (odds ratio [OR] 7.48; 95% confidence interval [CI]: 1.33-41.87, P=0.022), ASA physical status IV (OR 17.68; 95% CI: 4.53-68.94; P<0.001), and hypotension duration ≥15 min (OR 3.63; 95% CI: 1.11-11.87; P=0.033) were risk factors for fatal and near-fatal outcomes.

Conclusion: Most cases in this study were managed in a timely manner, but the epinephrine application should be optimized according to the guidelines. Age ≥65 years, ASA physical status IV, and long-term hypotension were risk factors for near-fatal and fatal outcomes.

Abstract Image

Abstract Image

Abstract Image

疑似危及生命的围手术期过敏反应的处理和近致命和致命结局的危险因素:一项中国回顾性研究。
目的:围手术期过敏反应(POA)是一种急性严重全身性过敏反应,其特征是危及生命的呼吸和循环衰竭。在我们之前的研究中,我们报道了中国疑似POA的流行病学。在本研究中,我们旨在阐明这些病例的管理和结果,并进一步验证接近致命和致命结果的危险因素。患者和方法:回顾性分析2018年9月至2019年8月在中国大陆112家三级医院就诊的447例疑似危及生命的POA病例。记录患者特征、症状、低血压持续时间、治疗方法和临床结果。双变量逻辑回归用于确定接近致命和致命结果的危险因素。结果:大多数疑似POA患者(89.9%)在5 min内被发现并得到治疗。232例(51.9%)患者采用肾上腺素作为初始治疗。皮质类固醇(26.6%)、其他血管活性药物(18.3%)和支气管扩张剂(1.6%)也被用作替代肾上腺素的初始治疗。根据过敏反应指南,肾上腺素的初始剂量(中位数,35µg)不足。在多变量分析中,年龄≥65岁(优势比[OR] 7.48;95%可信区间[CI]: 1.33-41.87, P=0.022), ASA身体状态IV (OR 17.68;95% ci: 4.53-68.94;PP=0.033)是致死性和接近致死性结局的危险因素。结论:本组病例大多得到了及时的处理,但肾上腺素的应用仍需按照指南进行优化。年龄≥65岁、ASA身体状态IV和长期低血压是致死性和致死性结局的危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信